Swedish Orphan Biovitrum AB (publ) provided earnings guidance for the third quarter and nine months ended September 2021. For the quarter, the company expected revenue in the third quarter is estimated at around SEK 3,760 million. Revenue for the year-to-date period is estimated at around SEK 10,630 million.